Category:Advancing Breakthrough Devices for Patients Act
Jump to navigation
Jump to search
“ | This bill amends the Federal Food, Drug, and Cosmetic Act to expand the Food and Drug Administration's (FDA's) priority review of breakthrough medical devices to include all classes of devices. Currently, only class III (new or highest risk) devices are eligible. (Via Congressional Research Service summary) | ” |
See also
External links
S.1077 (114th Congress): Advancing Breakthrough Devices for Patients Act of 2015, GovTrack. Reported by Committee on Mar 9, 2016.
This category currently contains no pages or media.